Vireo Growth (VREOF) Cash from Operations Growth (5y) (2025 - 2026)

Vireo Growth (VREOF) Cash from Operations Growth (5y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	88.58 Bn	86.72 Bn	-
2	Teva Pharmaceutical Industries	35.90 Bn	32.16 Bn	1.97 Bn
3	Zoetis	32.33 Bn	30.39 Bn	1.62 Bn
4	Takeda Pharmaceutical	27.49 Bn	23.43 Bn	4.39 Bn
5	United Therapeutics	23.14 Bn	20.99 Bn	648.10 Mn
6	RedHill Biopharma	20.53 Bn	20.53 Bn	-
7	Viatris	20.29 Bn	18.49 Bn	1.16 Bn
8	Neurocrine Biosciences	17.93 Bn	16.62 Bn	800.70 Mn
9	Elanco Animal Health	12.63 Bn	12.21 Bn	785.00 Mn
10	Vireo Growth	10.52 Bn	10.37 Bn	59.30 Mn

Download Data